CCR2 and neoplasm: Our results show that although Roscovitine alone induces a favorable TME by lowering PD-L1 expression, increasing CD8+ and NK cell infiltration, and reducing CCR2+ MDSCs, these changes did not decrease tumor growth or increase survival.